Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex Formation.
Stach L, Dinley EKH, Tournier N, Bingham RP, Gormley DA, Bramhall JL, Taylor A, Clarkson JE, Welbeck KA, Harris CL, Feeney M, Hughes JP, Sepp A, Batuwangala TD, Kitchen SJ, Nichols EM. Stach L, et al. Among authors: batuwangala td. Antibodies (Basel). 2021 Oct 12;10(4):39. doi: 10.3390/antib10040039. Antibodies (Basel). 2021. PMID: 34698051 Free PMC article.
Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept.
Walker A, Chung CW, Neu M, Burman M, Batuwangala T, Jones G, Tang CM, Steward M, Mullin M, Tournier N, Lewis A, Korczynska J, Chung V, Catchpole I. Walker A, et al. J Biol Chem. 2016 Mar 11;291(11):5500-5511. doi: 10.1074/jbc.M115.691162. Epub 2016 Jan 4. J Biol Chem. 2016. PMID: 26728464 Free PMC article.
Next generation immunotherapeutics--honing the magic bullet.
Enever C, Batuwangala T, Plummer C, Sepp A. Enever C, et al. Curr Opin Biotechnol. 2009 Aug;20(4):405-11. doi: 10.1016/j.copbio.2009.07.002. Epub 2009 Aug 24. Curr Opin Biotechnol. 2009. PMID: 19709876 Review.
A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
Zhang H, Yun S, Batuwangala TD, Steward M, Holmes SD, Pan L, Tighiouart M, Shin HJ, Koenig L, Park W, Rycroft D, Nannapaneni S, Wang Y, Chen ZG, Shin DM. Zhang H, et al. Among authors: batuwangala td. Int J Cancer. 2012 Aug 15;131(4):956-69. doi: 10.1002/ijc.26427. Epub 2011 Nov 19. Int J Cancer. 2012. PMID: 21918971 Free article.